Psychiatrist

Kathryn Brooke Renard, MD

412 6th Ave Fl 7, New York, New York, 10011-8409

About Kathryn Brooke Renard

Kathryn Brooke Renard is a psychiatrist based in New York, New York who is specialized in Psychiatry. Active license number of Kathryn Brooke Renard is 335138 for Psychiatry in New York. Her current practice location is 412 6th Ave Fl 7, New York. Patients can contact her at 850-692-9355. Kathryn Brooke Renard, MD, specializes in Psychiatry and her NPI number (Unique professional ID assigned by NPPES) is 1699425652.

Kathryn Brooke Renard specializes in the prevention, diagnosis, and treatment of mental disorders, emotional disorders, psychotic disorders, mood disorders, anxiety disorders, substance-related disorders, sexual and gender identity disorders and adjustment disorders. Biologic, psychological, and social components of illnesses are explored and understood in treatment of the whole person. Tools used may include diagnostic laboratory tests, prescribed medications, evaluation and treatment of psychological and interpersonal problems with individuals and families, and intervention for coping with stress, crises, and other problems.

Practice Information

Kathryn Brooke Renard's specialty, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.

Provider Name Kathryn Brooke Renard
Specialization Psychiatry
Credentials MD
Gender Female
Practice Address: 412 6th Ave Fl 7,
New York, NY - 10011-8409

Professional Identification Codes

NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to healthcare providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.

NPI Number1699425652
NPI Enumeration Date: 24 Mar, 2022
NPI Last Update On: 18 Apr, 2025

Medical Licenses:

Healthcare professionals can hold one or more medical licenses for different specialties in the same state or different states. Related medical licenses for Kathryn Brooke Renard are as mentioned below.

License NumberSpecializationStateStatus
335138Psychiatry New YorkPrimary

Mailing Address

Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned Practice address.

Kathryn Brooke Renard
281 1st Ave,
New York, NY - 10003

Book an Appointment with Kathryn Brooke Renard

To schedule an appointment, contact Kathryn Brooke Renard at 412 6th Ave Fl 7, New York, New York or call the phone number listed below.

Book an Appointment

Frequently Asked Questions

Below are some commonly asked questions about Kathryn Brooke Renard:

Kathryn Brooke Renard is a psychiatrist specializing in Psychiatry. She specializes in the prevention, diagnosis, and treatment of mental disorders, emotional disorders, psychotic disorders, mood disorders, anxiety disorders, substance-related disorders, sexual and gender identity disorders and adjustment disorders. Biologic, psychological, and social components of illnesses are explored and understood in treatment of the whole person. Tools used may include diagnostic laboratory tests, prescribed medications, evaluation and treatment of psychological and interpersonal problems with individuals and families, and intervention for coping with stress, crises, and other problems.

Yes, Kathryn Brooke Renard is currently accepting new patients. To schedule an appointment, contact the office directly and schedule an appointment.
*Availability may change. Please contact the office directly to ask about appointments.

Kathryn Brooke Renard practices at 412 6th Ave Fl 7, New York, New York, 10011-8409.

To schedule an appointment with Kathryn Brooke Renard, please contact the office at 850-692-9355.

Reviews & Feedback

Have you visited Kathryn Brooke Renard? Share your experience to help others looking for a psychiatrist in New York, NY.

Read Reviews / Give Feedback
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 September, 2026.